Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Colorcon

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Nepicastat


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Nepicastat?

Nepicastat is an investigational drug.

There have been 4 clinical trials for Nepicastat. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Biotie Therapies Inc., National Institute on Drug Abuse (NIDA), and Acorda Therapeutics.

There are twenty-eight US patents protecting this investigational drug and three hundred and twelve international patents.

Recent Clinical Trials for Nepicastat
TitleSponsorPhase
A Multi-Center Trial of Nepicastat for Cocaine DependenceNational Institute on Drug Abuse (NIDA)Phase 2
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF VeteransAcorda TherapeuticsPhase 2
Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF VeteransBaylor College of MedicinePhase 2

See all Nepicastat clinical trials

Clinical Trial Summary for Nepicastat

Top disease conditions for Nepicastat
Top clinical trial sponsors for Nepicastat

See all Nepicastat clinical trials

US Patents for Nepicastat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nepicastat ⤷  Try it Free Process for preparing 1,3-dihydroimidazole-2-thione derivatives Bial-Portela & CA, S.A. (S. Mamede do Coronado, PT) ⤷  Try it Free
Nepicastat ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Nepicastat ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Nepicastat ⤷  Try it Free 1,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury Bial-Portela & CA, S.A. (S. Mamede do Coronado, PT) ⤷  Try it Free
Nepicastat ⤷  Try it Free Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Nepicastat ⤷  Try it Free DBH inhibitors for treating memory loss Brandeis University (Waltham, MA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Nepicastat

Drugname Country Document Number Estimated Expiration Related US Patent
Nepicastat European Patent Office EP2726454 2031-06-29 ⤷  Try it Free
Nepicastat Spain ES2667099 2031-06-29 ⤷  Try it Free
Nepicastat Japan JP2014520796 2031-06-29 ⤷  Try it Free
Nepicastat Japan JP5981539 2031-06-29 ⤷  Try it Free
Nepicastat Portugal PT2726454 2031-06-29 ⤷  Try it Free
Nepicastat World Intellectual Property Organization (WIPO) WO2013002660 2031-06-29 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.